Literature DB >> 8655211

Incidence and mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa serotype O11 isolates.

M Kettner1, P Milosovic, M Hletková, J Kallová.   

Abstract

Mechanisms of resistance to five aminoglycoside antibiotics: gentamicin (G), tobramycin (T), netilmicin (N), amikacin (A) and isepamicin (I), were assessed in 16 clinical isolates of Pseudomonas aeruginosa serotype O11, originating from five hospitals in Bratislava. All isolates were in vitro highly resistant to all mentioned aminoglycoside antibiotics (MIC > 32 mg/l). Thirteen isolates produced three aminoglycoside-modifying enzymes (AGME), responsible for resistance to the respective aminoglycosides: AAC(6')-I (T, N, A); APH (2") (G, T); APH (3')-VI (I). In addition to this, in four isolates a production of AAC(3)-II (G, T, N) was observed. In three isolates no production of AGME was observed. The strains studied were isolated mainly from urine. Several isolates were able to transfer aminoglycoside resistance by bacterial conjugation to P. aeruginosa 1008 rifr recipient. The transconjugants from these transfers expressed the same resistance pattern and nearly the same mechanisms of resistance as the donor strains.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8655211     DOI: 10.1007/bf01713571

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  12 in total

Review 1.  Antimicrobial agent therapy for Pseudomonas aeruginosa.

Authors:  J A Korvick; V L Yu
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

3.  Cloning and characterization of an AAC(6') gene from Serratia marcescens.

Authors:  H M Champion; P M Bennett; D A Lewis; D S Reeves
Journal:  J Antimicrob Chemother       Date:  1988-11       Impact factor: 5.790

4.  Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics.

Authors:  J Watine; C Bourrel; B Dubourdieu; J L Gineston; P Bories; M Durand; A Marre; F Formosa; M P Brunel; J Palliez
Journal:  Pathol Biol (Paris)       Date:  1994-04

5.  Serotypes and extended spectrum beta-lactam resistance in aminoglycoside resistant Pseudomonas aeruginosa isolates from two Belgian general hospitals: a seven year study.

Authors:  R Vanhoof; C Godard; E Nulens; H J Nyssen; C Wildemauwe; J M Hubrechts; P Maes; E Hannecart-Pokorni
Journal:  J Hosp Infect       Date:  1993-06       Impact factor: 3.926

6.  Serological typing of Pseudomonas aeruginosa: use of commercial antisera and live antigens.

Authors:  C D Brokopp; R Gomez-Lus; J J Farmer
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

Review 7.  Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes.

Authors:  K J Shaw; P N Rather; R S Hare; G H Miller
Journal:  Microbiol Rev       Date:  1993-03

8.  Hospital outbreaks caused by Pseudomonas aeruginosa: importance of serogroup O11.

Authors:  J J Farmer; R A Weinstein; C H Zierdt; C D Brokopp
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

9.  Survey of susceptibility to selected antibiotics of Pseudomonas aeruginosa strains isolated from patients with tumor disease and their relationship to serotype.

Authors:  B Zatkovic; J Trupl; V Majtán
Journal:  Folia Microbiol (Praha)       Date:  1993       Impact factor: 2.099

10.  Transferable amikacin resistance in gram-negative bacterial isolates.

Authors:  J Kallová; T Macicková; A Majtánová; A Aghová; D Adam; M Kettner
Journal:  Chemotherapy       Date:  1995 May-Jun       Impact factor: 2.544

View more
  8 in total

Review 1.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

2.  Occurrence of endemic plasmids causing beta-lactam resistance in Enterobacteriaceae in children's university hospital in Munich.

Authors:  S Benczeová; D Adam; M Vrábelová; D Michálková-Papajová; M Kettner
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

3.  The Construction of Carbon Nanotubes Containing an Anti-Bacterial Chemical Component and its Effect on MDR and XDR Isolates of Pseudomonas Aeruginosa.

Authors:  Kamelia Banihashemi; Behnam Sobouti; Iraj Mehregan; Ronak Bakhtiari; Nour Amirmozafari
Journal:  Rep Biochem Mol Biol       Date:  2020-04

4.  Pseudomonas aeruginosa: resistance to the max.

Authors:  Keith Poole
Journal:  Front Microbiol       Date:  2011-04-05       Impact factor: 5.640

5.  Population structure of Pseudomonas aeruginosa from five Mediterranean countries: evidence for frequent recombination and epidemic occurrence of CC235.

Authors:  Makaoui Maatallah; Jihane Cheriaa; Amina Backhrouf; Aina Iversen; Hajo Grundmann; Thuy Do; Philippe Lanotte; Maha Mastouri; Mohamed Salem Elghmati; Fernando Rojo; Snoussi Mejdi; Christian G Giske
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

6.  Aminoglycoside-Modifying Enzymes Are Sufficient to Make Pseudomonas aeruginosa Clinically Resistant to Key Antibiotics.

Authors:  Aswin Thacharodi; Iain L Lamont
Journal:  Antibiotics (Basel)       Date:  2022-07-01

7.  Pseudomonas aeruginosa population structure revisited.

Authors:  Jean-Paul Pirnay; Florence Bilocq; Bruno Pot; Pierre Cornelis; Martin Zizi; Johan Van Eldere; Pieter Deschaght; Mario Vaneechoutte; Serge Jennes; Tyrone Pitt; Daniel De Vos
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

8.  Prevalence of Multidrug-resistant, Extensively Drug-resistant, and Pandrug-resistant Pseudomonas aeruginosa from a Tertiary Level Intensive Care Unit.

Authors:  J S Gill; Sunil Arora; S P Khanna; Kvs Hari Kumar
Journal:  J Glob Infect Dis       Date:  2016 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.